Clinical Trials Directory

Trials / Unknown

UnknownNCT05314647

Lutein Supplementation in Healthy Children

Effects of Lutein Supplementation on Cognition and Vision in Healthy Children With Screen Time Exposure: A Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Northcentral University · Academic / Other
Sex
All
Age
8 Years – 16 Years
Healthy volunteers
Accepted

Summary

This is a single site, randomized, double-blind placebo controlled parallel arm study assessing the effects of 6 months lutein supplementation on cognitive and visual outcomes in healthy children exposed to excessive digital screen time.

Detailed description

Studies in humans and primates have also shown that appropriate daily intake of lutein provides protection to the eyes from blue light from screen time devices such as computers, televisions and phones. It has been well-documented that children are spending far over the recommended two hours screen time per day and excessive exposure to the high energy blue light associated with digital devices has been shown to cause both short-term and long-term visual damage as well as disruption to the sleep cycle. With a globally aging population, if this deficit is not addressed adequately early on in life then there will be substantial public health consequences. A recent study predicted that if individuals were to consume the recommended levels of lutein and zeaxanthin daily, there would be a seven percent reduced risk for age related eye disease and a potential savings of over five billion US dollars annually.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTluteindaily dose of 5 mg lutein
DIETARY_SUPPLEMENTplacebodaily dose of 0 mg lutein

Timeline

Start date
2023-07-15
Primary completion
2024-03-01
Completion
2024-05-01
First posted
2022-04-06
Last updated
2023-11-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05314647. Inclusion in this directory is not an endorsement.